Successful treatment of low‐risk myelodysplastic syndrome‐related anemia in patients with chronic kidney disease with daprodustat: A report of two cases

Abstract Anemia is a major clinical manifestation seen in myelodysplastic syndromes (MDS). Treatment options for anemia in low‐risk MDS are limited. Especially, oral medication which is uniformly effective for anemia in low‐risk MDS is required. Hypoxia‐inducible factor (HIF) prolyl hydroxylase (HIF...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Hiroyoshi Kunimoto, Takayuki Sakuma, Takuma Ohashi, Mayoko Shirafuta, Hiroshi Teranaka, Hideaki Nakajima
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Wiley 2024-12-01
Schriftenreihe:	eJHaem
Schlagworte:	anemia case report daprodustat MDS
Online-Zugang:	https://doi.org/10.1002/jha2.1057
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!